- Company Overview for LLOYD JONES PHARMA LIMITED (13828575)
- Filing history for LLOYD JONES PHARMA LIMITED (13828575)
- People for LLOYD JONES PHARMA LIMITED (13828575)
- More for LLOYD JONES PHARMA LIMITED (13828575)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
15 Jul 2024 | AA | Total exemption full accounts made up to 31 March 2024 | |
30 Apr 2024 | CS01 | Confirmation statement made on 2 April 2024 with no updates | |
19 Oct 2023 | PSC05 | Change of details for D.R. Cecil Jones & Son Limited as a person with significant control on 1 March 2022 | |
19 Oct 2023 | AA | Total exemption full accounts made up to 31 March 2023 | |
26 May 2023 | CS01 | Confirmation statement made on 13 May 2023 with no updates | |
13 May 2022 | CS01 | Confirmation statement made on 13 May 2022 with updates | |
13 May 2022 | AP01 | Appointment of Mr Jonathan Lloyd-Jones as a director on 3 May 2022 | |
13 May 2022 | TM01 | Termination of appointment of Niki Jay Watts as a director on 3 May 2022 | |
31 Mar 2022 | AA | Accounts for a dormant company made up to 31 March 2022 | |
22 Mar 2022 | AA01 | Current accounting period shortened from 31 January 2023 to 31 March 2022 | |
07 Mar 2022 | SH01 |
Statement of capital following an allotment of shares on 1 March 2022
|
|
05 Jan 2022 | NEWINC |
Incorporation
Statement of capital on 2022-01-05
|